Manufacturing challenges in regenerative medicine.
Where this comes from
- Record sourced from PubMed, PMID 24739757.
- Also identified by DOI 10.1126/scitranslmed.3008558.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Along with scientific and regulatory issues, the translation of cell and tissue therapies in the routine clinical practice needs to address standardization and cost-effectiveness through the definition of suitable manufacturing paradigms.
Medical subject headings
- Cell- and Tissue-Based Therapy
- Regenerative Medicine
- Tissue Engineering